Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.

Bill would rein in “pharmacy benefit managers,” or PBMs, which have come under fire for driving up prescription drug costs ...

One initiative that has been scrapped would have offered some generic drugs to Medicare enrollees for $2. Meanwhile, the Trump administration has backed off hospice oversight.

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Cigna’s CFO, Brian Evanko, addressed financial and operational updates at the Barclays Healthcare Conference. The company ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

On Tuesday in Hartford, a task force of legislators presented a series of recommendations to bring down the cost of ...

The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by ...

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of ...

The FCCPC has resolved to take decisive action against the soaring cost of medications in Nigeria, particularly life-saving drugs for hypertension and diabetes. Representing the FCCPC Vice Chairman, ...

Feb. 26, 2025 /PRNewswire/ -- Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, is proud to announce the addition of drug cost information to its ...

The Federal Competition and Consumer Protection Commission (FCCPC), has launched an inquiry into the high cost of drugs and price disparities across Nigeria. The Inquiry, which began on Wednesday in ...